A comparison of helical intensity-modulated radiotherapy, intensity-modulated radiotherapy, and 3d-conformal radiation therapy for pancreatic cancer

Medical Dosimetry

Volumn 36, Issue 4, 2011, Pages 351-357

  Poppe, Matthew M ^a,b   Narra, Venkat ^a,b   Yue, Ning J ^a,b   Zhou, Jinghao ^a,b   Nelson, Carl ^a,b   Jabbour, Salma K ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Helical; IMRT; Pancreatic; Tomotherapy

Indexed keywords

ARTICLE; BREATHING MECHANICS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; HELICAL INTENSITY MODULATED RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; INTESTINE; KIDNEY; LINAC BASED INTENSITY MODULATED RADIOTHERAPY; LIVER; PANCREAS CANCER; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; RADIATION DOSE; SPINAL CORD; STOMACH; THREE DIMENSIONAL COMPUTER ASSISTED RADIOTHERAPY; VOLUMETRY;

ALGORITHMS; HUMANS; INTESTINES; KIDNEY; LIVER; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; STOMACH;

EID: 80755136701     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2010.08.003     Document Type: Article

References (12)

1. Neoptolemos J.P., Dunn J.A., Stocken D.D., et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001, 358:1576-1585.
2. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J. Med. 2004, 350:1200-1210.
3. Koshy M.C., Landry J.C., Cavanaugh S.X., et al. A challenge to the therapeutic nihilism of ESPAC-1. Int. J. Radiat. Oncol. Biol. Phys. 2005, 61:965-966.
4. Yovino S., Poppe M., Jabbour S., et al. Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers. Int. J. Radiat. Oncol. Biol. Phys. 2010.
5. Ben-Josef E., Shields A.F., Vaishampayan U., et al. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59:454-459.
6. Landry J.C., Yang G.Y., Ting J.Y., et al. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (Vara): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Med. Dosim. 2002, 27:121-129.
7. Brown M.W., Ning H., Arora B., et al. A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65:274-283.
8. Lee T.F., Fang F.M., Chao P.J., et al. Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma. Radiother. Oncol. 2008, 89:89-96.
9. Sheng K., Molloy J.A., Larner J.M., et al. A dosimetric comparison of non-coplanar IMRT versus helical Tomotherapy for nasal cavity and paranasal sinus cancer. Radiother. Oncol. 2007, 82:174-178.
10. Baglan K.L., Frazier R.C., Yan D., et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002, 52:176-183.
11. Lu W. Real-time motion-adaptive delivery (MAD) using binary MLC. II. Rotational beam (tomotherapy) delivery. Phys. Med. Biol. 2008, 53:6513-6531.
12. Welsh J.S., Lock M., Harari P.M., et al. Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Technol. Cancer Res. Treat. 2006, 5:465-479.